NCT01890941View on ClinicalTrials.gov

A Late Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Primary Completion Date

March 31, 2014

Conditions
Dry Eye Syndromes
Interventions
DRUG

KCT-0809 ophthalmic solution

DRUG

Placebo

Trial Locations (1)

Unknown

Tokyo and Other Japanese City

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY

NCT01890941 - A Late Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes | Biotech Hunter | Biotech Hunter